FMRP drives mRNP targets into translationally silenced complexes.

Area of Science:

• Molecular Biology
• Genetics
• Neuroscience

Background:

• Fragile X syndrome (FXS) is caused by a deficiency in the fragile X protein (FMRP).
• FMRP is an RNA-binding protein crucial for normal cognitive function.
• Existing models primarily attribute FMRP's function to ribosome stalling during translation.

Purpose of the Study:

• To elucidate the primary mechanism of translational repression by FMRP.
• To investigate FMRP's role in translation initiation and mRNA regulation.
• To identify the molecular interactions governing FMRP's function in FXS.

Main Methods:

• Immunoprecipitation and polysome profiling of cell lysates.
• Liquid chromatography-tandem mass spectrometry (LC-MS/MS) for protein identification.
• Analysis of FMRP's interaction with translation initiation factors and mRNA.

Main Results:

• Mammalian FMRP predominantly represses translation initiation by preventing 40S ribosomal subunit binding.
• FMRP associates with target mRNAs by binding eukaryotic translation initiation factor 4E (eIF4E) at the 5' cap, competing with eIF4G1.
• Ataxin-2-like and FMRP's KH1+KH2 domains facilitate mRNA binding and sequestration.

Conclusions:

• FMRP primarily inhibits translation by sequestering mRNA targets from initiation machinery.
• This mechanism involves FMRP's interaction with eIF4E, mRNA, and poly(A)-binding proteins.
• Findings offer a new perspective on FXS pathogenesis and FMRP function beyond ribosome stalling.